Asset
Lidocaine
Scilex Holding Company Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01591616 | phase4 | completed | 2010-04-01 | 2012-04-01 | Dentsply International | Pediatric Study to Access Pharmacokinetics and Safety of Oraqix Gel |
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 207962 | NDA | SCILEX PHARMACEUTICALS INC |
Marketed products (1)
- ZTLIDO